Otonomy to Present at the J.P. Morgan Healthcare Conference
January 04 2018 - 7:30AM
Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
diseases and disorders of the ear, today announced that David A.
Weber, Ph.D., president and chief executive officer, will present
at the 36th Annual J.P. Morgan Healthcare Conference on Thursday,
January 11, 2018 at 8:30 a.m. PST (11:30 a.m. EST) at the Westin
St. Francis Hotel in San Francisco.
A live audio webcast of the presentation and breakout question
and answer session will be available through the Events and
Presentations page of the company's website (www.otonomy.com).
About Otonomy
Otonomy is a biopharmaceutical company dedicated to the
development of innovative therapeutics for diseases and disorders
of the ear. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs including Ménière’s disease, hearing loss, and
tinnitus. For additional information please visit
www.otonomy.com.
Contacts:Investor InquiriesWestwicke
PartnersRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Apr 2023 to Apr 2024